Data as of 10:45am ET
| -0.20 / -2.92%|
The 4 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 15.50, with a high estimate of 20.00 and a low estimate of 12.00. The median estimate represents a +133.08% increase from the last price of 6.65.
The current consensus among 4 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.